Meeting Banner
Abstract #1075

3T MRI and MR Spectroscopy of a Feline Model of Sandhoff Disease After AAV-Mediated Gene Therapy

Heather L. Gray-Edwards1, Nouha Salibi2, Diane Wilson1, Ashley Randle1, Ronald J. Beyers3, Thomas Stewart Denney3, Ravi T. Seethamraju2, Shumin Wang3, Xiaotong Sun3, Allison M. Bradbury4, Victoria J. McCurdy4, Aime K. Johnson5, Nancy Cox1, Douglas R. Martin, 14

1Scott-Ritchey Research Center, Auburn University, Auburn, Al, United States; 2MR R&D, Siemens Healthcare, Malvern, PA, United States; 3Department of Electrical and Computer Engineering, Auburn Univeristy, Auburn, AL, United States; 4Anatomy, Physiology and Pharmacology, Auburn University, Auburn, Al, United States; 5Clinical Sciences, Auburn University, Auburn, Al, United States

Sandhoff disease (SD) is a form of GM2 gangliosidosis in humans that is untreatable and fatal by 5 years of age. Thee feline SD model has the same subunit mutation as Sandhoff patients. AAV2/rh8 vectors expressing feline hexosaminidase subunits were injected bilaterally into the thalamus and deep cerebellar nuclei of SD cats. MR images and Magnetic Resonance Spectroscopy (MRS) data were acquired on a 3 Tesla MAGNETOM Verio scanner. Untreated SD cat shows gray:white matter inversion and elevations of brain metabolites. Gene replacement in the feline SD model results in restoration of both brain architecture and metabolites.

Abstract PDF

Keywords

abnormalities abstract amelioration analyzed anatomical anatomy animals architecture array attenuation auburn audience axial benefit better bilaterally brain brains buildup cats caused cerebellar channel chemical chess choline clinical closely coil computer consistent control coronal corp cortex cortical decreased deep defined determination development disease diseases electrical elevated endpoint engineering enzyme evaluate expressing external fatal feline fold form future gene gradient gray heather homepage human humane humans in vivo individual injected integrals intensities interface invasive isotropic lifespan located magnetization marked martin matched mediated merge metabolism metabolite metabolites model months mutation near normalization normalized nuclei outcomes outlined parietal peak phantom pharmacology physiology placed placement planned planning possibly predicting prepared preservation press production profound progression psychiatry quantification radiology rapid rather reduced replacement resolution resolved respectively revealed scanner sciences secondary selective signs similarly software solution spectroscopy stages storage structures studies subunit subunits success suppression target thalamus therapy treated trials understanding untreated user variations vectors vital water white wrist years